Eurofins Genomics and Olink partner to advance proteomics research
Drug Discovery World
SEPTEMBER 20, 2023
Eurofins Genomics has adopted Olink technology to advance proteomics research and accelerate its precision medicine programmes. Olink Explore HT is the company's latest solution for high-throughput proteomics, allowing scientists to accurately measure over 5,300 proteins [.] Not yet a DDW member?
Let's personalize your content